Technical Analysis for EVOK - Evoke Pharma, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.47 | 0.00% | 0.00 |
EVOK closed unchanged on Wednesday, May 8, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 13
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
20 DMA Resistance | Bearish | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
20 DMA Resistance | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% |
Alert | Time |
---|---|
Possible NR7 | about 17 hours ago |
Possible Inside Day | about 17 hours ago |
Rose Above 20 DMA | about 19 hours ago |
Up 2% | about 19 hours ago |
Up 1% | about 19 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Evoke Pharma, Inc., a specialty pharmaceutical company, engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It is developing EVK-001, a metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded in 2007 and is headquartered in San Diego, California.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Disease Diabetes Gastrointestinal Gastroenterology Diabetes Mellitus Chloroarenes Antiemetics Benzamides Nasal Spray Gastrointestinal Disorders Gastroparesis Metoclopramide Prolactin Releasers
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.158 |
52 Week Low | 0.4104 |
Average Volume | 32,009 |
200-Day Moving Average | 0.98 |
50-Day Moving Average | 0.56 |
20-Day Moving Average | 0.47 |
10-Day Moving Average | 0.46 |
Average True Range | 0.06 |
RSI (14) | 43.18 |
ADX | 16.04 |
+DI | 20.45 |
-DI | 10.95 |
Chandelier Exit (Long, 3 ATRs) | 0.43 |
Chandelier Exit (Short, 3 ATRs) | 0.60 |
Upper Bollinger Bands | 0.53 |
Lower Bollinger Band | 0.41 |
Percent B (%b) | 0.48 |
BandWidth | 24.84 |
MACD Line | -0.03 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0075 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.50 | ||||
Resistance 3 (R3) | 0.50 | 0.49 | 0.49 | ||
Resistance 2 (R2) | 0.49 | 0.48 | 0.49 | 0.49 | |
Resistance 1 (R1) | 0.48 | 0.48 | 0.48 | 0.48 | 0.49 |
Pivot Point | 0.47 | 0.47 | 0.47 | 0.47 | 0.47 |
Support 1 (S1) | 0.46 | 0.46 | 0.46 | 0.46 | 0.45 |
Support 2 (S2) | 0.45 | 0.46 | 0.45 | 0.45 | |
Support 3 (S3) | 0.44 | 0.45 | 0.45 | ||
Support 4 (S4) | 0.44 |